These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

855 related items for PubMed ID: 19721130

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Analysis of platelet alpha2-adrenergic receptor activity in stable coronary artery disease patients on dual antiplatelet therapy.
    Béres BJ, Tóth-Zsámboki E, Vargová K, László A, Masszi T, Kerecsen G, Préda I, Kiss RG.
    Thromb Haemost; 2008 Nov; 100(5):829-38. PubMed ID: 18989527
    [Abstract] [Full Text] [Related]

  • 5. Antiplatelet drug response variability and the role of platelet function testing: a practical guide for interventional cardiologists.
    Angiolillo DJ, Suryadevara S, Capranzano P, Zenni MZ, Guzman LA, Bass TA.
    Catheter Cardiovasc Interv; 2009 Jan 01; 73(1):1-14. PubMed ID: 19089929
    [Abstract] [Full Text] [Related]

  • 6. Variability in platelet response to the antiplatelet agents aspirin and clopidogrel: mechanisms, measurement, and clinical relevance.
    Jennings LK.
    Crit Pathw Cardiol; 2009 Mar 01; 8(1):20-8. PubMed ID: 19258834
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Platelet function monitoring in patients with coronary artery disease.
    Gurbel PA, Becker RC, Mann KG, Steinhubl SR, Michelson AD.
    J Am Coll Cardiol; 2007 Nov 06; 50(19):1822-34. PubMed ID: 17980247
    [Abstract] [Full Text] [Related]

  • 9. Comparison of methods to evaluate clopidogrel-mediated platelet inhibition after percutaneous intervention with stent implantation.
    Gremmel T, Steiner S, Seidinger D, Koppensteiner R, Panzer S, Kopp CW.
    Thromb Haemost; 2009 Feb 06; 101(2):333-9. PubMed ID: 19190818
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Mechanisms of platelet activation: need for new strategies to protect against platelet-mediated atherothrombosis.
    Jennings LK.
    Thromb Haemost; 2009 Aug 06; 102(2):248-57. PubMed ID: 19652875
    [Abstract] [Full Text] [Related]

  • 12. Measuring antiplatelet drug effects in the laboratory.
    Harrison P, Frelinger AL, Furman MI, Michelson AD.
    Thromb Res; 2007 Aug 06; 120(3):323-36. PubMed ID: 17239428
    [Abstract] [Full Text] [Related]

  • 13. Oral antiplatelet therapy in PCI patients.
    Sharma SK.
    Catheter Cardiovasc Interv; 2010 Mar 01; 75 Suppl 1():S7-14. PubMed ID: 20333709
    [Abstract] [Full Text] [Related]

  • 14. Clopidogrel resistance?
    Gurbel PA, Tantry US.
    Thromb Res; 2007 Mar 01; 120(3):311-21. PubMed ID: 17109936
    [Abstract] [Full Text] [Related]

  • 15. Latest clinical data on testing for high on-treatment platelet reactivity.
    Fileti L, Campo G, Valgimigli M.
    Rev Cardiovasc Med; 2011 Mar 01; 12 Suppl 1():S14-22. PubMed ID: 22080983
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Recent advance in antiplatelet therapy: the mechanisms, evidence and approach to the problems.
    Horiuchi H.
    Ann Med; 2006 Mar 01; 38(3):162-72. PubMed ID: 16720431
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 43.